Our Science – Metwalli Website
Adam R. Metwalli, M.D.
Dr. Metwalli is an active member of the Society of Urologic Oncology, the American Urological Association, the American College of Surgeons, and a member of the Medical Advisory Board for the National Kidney Foundation--Maryland.
Dr. Metwalli's research interests are in apoptosis pathways in kidney, bladder and prostate cancer. His previous research involved sensitizing urothelial and prostate carcinoma cells to TRAIL-induced apoptosis using small molecule analogs of Second Mitochondrial Activators of Caspases (SMAC) as well as chemotherapy and interferon. He also has an interest in the androgen pathways in normal and neoplastic prostate cancer with a specific emphasis on the enzymatic function of 3-alpha-hydroxysteroid dehydrogenase (AKR1C3) and the androgen receptor.
This page was last updated on 3/6/2014.